Search












The lists contain medicinal products or product categories subject to prescription which shall not bear the safety features (White list) and medicinal products or product categories not subject to prescription which shall bear the safety features (Black list)
Number of records: 6132
Name of the medicinal product Supplement
SÚKL code Registration Number SPC ? PIL ? ATC group MA status ?
IRBESARTAN/HYDROCHLOROTHIAZID TEVA 300MG/25MG TBL FLM 50X1 II
0167348 EU/1/09/583/072 irbesartan.pdf irbesartan.pdf C09DA04 R
IRBESARTAN/HYDROCHLOROTHIAZID TEVA 150MG/12,5MG TBL FLM 7 I
0167277 EU/1/09/583/001 irbesartan.pdf irbesartan.pdf C09DA04 R
IRBESARTAN/HYDROCHLOROTHIAZID TEVA 150MG/12,5MG TBL FLM 14 I
0167278 EU/1/09/583/002 irbesartan.pdf irbesartan.pdf C09DA04 R
IRBESARTAN/HYDROCHLOROTHIAZID TEVA 150MG/12,5MG TBL FLM 15 I
0167279 EU/1/09/583/003 irbesartan.pdf irbesartan.pdf C09DA04 R
IRBESARTAN/HYDROCHLOROTHIAZID TEVA 150MG/12,5MG TBL FLM 20 I
0167280 EU/1/09/583/004 irbesartan.pdf irbesartan.pdf C09DA04 R
IRBESARTAN/HYDROCHLOROTHIAZID TEVA 150MG/12,5MG TBL FLM 28 I
0167281 EU/1/09/583/005 irbesartan.pdf irbesartan.pdf C09DA04 R
IRBESARTAN/HYDROCHLOROTHIAZID TEVA 150MG/12,5MG TBL FLM 30 I
0167282 EU/1/09/583/006 irbesartan.pdf irbesartan.pdf C09DA04 R
IRBESARTAN/HYDROCHLOROTHIAZID TEVA 150MG/12,5MG TBL FLM 56 I
0167283 EU/1/09/583/007 irbesartan.pdf irbesartan.pdf C09DA04 R
IRBESARTAN/HYDROCHLOROTHIAZID TEVA 150MG/12,5MG TBL FLM 60 I
0167284 EU/1/09/583/008 irbesartan.pdf irbesartan.pdf C09DA04 R
IRBESARTAN/HYDROCHLOROTHIAZID TEVA 150MG/12,5MG TBL FLM 90 I
0167285 EU/1/09/583/009 irbesartan.pdf irbesartan.pdf C09DA04 R
IRBESARTAN/HYDROCHLOROTHIAZID TEVA 150MG/12,5MG TBL FLM 98 I
0167286 EU/1/09/583/010 irbesartan.pdf irbesartan.pdf C09DA04 R
IRBESARTAN/HYDROCHLOROTHIAZID TEVA 150MG/12,5MG TBL FLM 100 I
0167287 EU/1/09/583/011 irbesartan.pdf irbesartan.pdf C09DA04 R
IRBESARTAN/HYDROCHLOROTHIAZID TEVA 150MG/12,5MG TBL FLM 50X1 I
0167288 EU/1/09/583/012 irbesartan.pdf irbesartan.pdf C09DA04 R
IRBESARTAN/HYDROCHLOROTHIAZID TEVA 150MG/12,5MG TBL FLM 7 II
0167289 EU/1/09/583/013 irbesartan.pdf irbesartan.pdf C09DA04 R
IRBESARTAN/HYDROCHLOROTHIAZID TEVA 150MG/12,5MG TBL FLM 14 II
0167290 EU/1/09/583/014 irbesartan.pdf irbesartan.pdf C09DA04 R
IRBESARTAN/HYDROCHLOROTHIAZID TEVA 150MG/12,5MG TBL FLM 15 II
0167291 EU/1/09/583/015 irbesartan.pdf irbesartan.pdf C09DA04 R
IRBESARTAN/HYDROCHLOROTHIAZID TEVA 150MG/12,5MG TBL FLM 20 II
0167292 EU/1/09/583/016 irbesartan.pdf irbesartan.pdf C09DA04 R
IRBESARTAN/HYDROCHLOROTHIAZID TEVA 150MG/12,5MG TBL FLM 28 II
0167293 EU/1/09/583/017 irbesartan.pdf irbesartan.pdf C09DA04 R
IRBESARTAN/HYDROCHLOROTHIAZID TEVA 150MG/12,5MG TBL FLM 30 II
0167294 EU/1/09/583/018 irbesartan.pdf irbesartan.pdf C09DA04 R
IRBESARTAN/HYDROCHLOROTHIAZID TEVA 150MG/12,5MG TBL FLM 56 II
0167295 EU/1/09/583/019 irbesartan.pdf irbesartan.pdf C09DA04 R

‹‹ ‹ 50 60 70 80 90 98 99 100 101 102 103 104 105 106 107 108 110 120 130 140 150 200 300 › ››

Medicinal products reimbursed from health insurance are blue-tinged and marked with sign.

Medicinal products on the Czech market in line with periodical report from wholesalers in last 3 months (with monthly distance) are sign and are typed in bold

Last update of registration information: 11. January 2022 at 00:10
Last update of price and payment data: 1. January 2022 at 00:11